US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apimeds Pharmaceutical U.S, Inc.

2.26

-0.0294-1.28%

Volume:23.87K

Turnover:56.25K

Market Cap:3.41M

PE:-0.06

High:2.47

Open:2.30

Low:2.21

Close:2.29

52wk High:59.70

52wk Low:2.17

Shares:1.51M

Float Shares:304.73K

Volume Ratio:1.04

T/O Rate:7.83%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-38.5450

EPS(LYR):-0.1759

ROE:-144.99%

ROA:-69.29%

PB:0.42

PE(LYR):-12.85

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Apimeds Pharmaceuticals US Enters Assignment and Transfer Agreement with Freet on August 19

Apimeds Secures Key Apitox Rights via FreeT Agreement

Apimeds Pharmaceuticals US - Freet Assigns All Apitox-Related Rights to Apimeds Pharmaceuticals - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals US - Receives 100% Korean Clinic Rights, 25% U.S. Royalty, 25% Overseas Revenue Participation for Apitox - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/APUS"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","market":"US","secType":"STK","nameCN":"Apimeds Pharmaceutical  U.S, Inc.","latestPrice":2.2606,"timestamp":1789059871618,"preClose":2.29,"halted":0,"volume":23866,"delay":0,"changeRate":-0.012838427947598197,"floatShares":304730,"shares":1509119,"eps":-38.545,"marketStatus":"Trading","change":-0.0294,"latestTime":"09-10 13:04:59 EDT","open":2.3,"high":2.47,"low":2.2107,"amount":56251.054617600006,"amplitude":0.113231,"askPrice":2.37,"askSize":100,"bidPrice":2.23,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-38.545,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"listingDate":1746763200000,"exchange":"AMEX","adjPreClose":2.29,"preHourTrading":{"tag":"盘前","latestPrice":2.27,"preClose":2.29,"latestTime":"09:13 EDT","volume":253,"amount":588.682171,"timestamp":1789045999709,"change":-0.02,"changeRate":-0.008734,"amplitude":0.259258},"postHourTrading":{"tag":"盘后","latestPrice":2.29,"preClose":2.29,"latestTime":"19:29 EDT","volume":35,"amount":74.63,"timestamp":1788996587383,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.04295},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","floatShares":304730,"roa":"-69.29%","roe":"-144.99%","lyrEps":-0.175862,"volumeRatio":1.04295,"shares":1509119,"dividePrice":0,"high":2.47,"amplitude":0.113231,"preClose":2.29,"low":2.2107,"week52Low":2.17,"pbRate":"0.42","week52High":59.7,"institutionHeld":0,"latestPrice":2.2606,"committee":-0.941748,"eps":-38.545,"divideRate":0,"volume":23866,"delay":0,"ttmEps":-38.545,"open":2.3,"prevYearClose":16.4,"prevWeekClose":2.42,"prevMonthClose":3.88,"prevQuarterClose":9,"fiveDayClose":2.63,"twentyDayClose":4.66,"sixtyDayClose":13.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APUS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-24","symbol":"APUS","defaultRemindTime":1784899800000,"type":"split","dateTimestamp":1784865600000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APUS","date":"2025-12-01","current":-0.059411,"percent":0.642384,"low":-37.866629,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"high":-4.754876,"avg":-11.953693,"sd":7.073766,"marketCap":36470350},"quantilePoints":[{"date":"2025-02-21","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-02-28","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-03-05","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-05-09","current":-18.309826,"twenty":-34.716764,"median":-34.716764,"eighty":-33.299512,"marketCap":25450475},{"date":"2025-05-16","current":-14.148502,"twenty":-34.716764,"median":-34.008138,"eighty":-15.063993,"marketCap":19666276},{"date":"2025-05-23","current":-14.074662,"twenty":-34.716764,"median":-18.309826,"eighty":-14.306662,"marketCap":21054484},{"date":"2025-05-30","current":-13.387434,"twenty":-34.716764,"median":-15.063993,"eighty":-14.061031,"marketCap":20026450},{"date":"2025-06-06","current":-14.702962,"twenty":-34.716764,"median":-14.800251,"eighty":-13.996937,"marketCap":21994367},{"date":"2025-06-13","current":-14.314495,"twenty":-34.716764,"median":-14.564634,"eighty":-14.061031,"marketCap":21413253},{"date":"2025-06-20","current":-13.774354,"twenty":-33.866413,"median":-14.548195,"eighty":-14.0474,"marketCap":20605249},{"date":"2025-06-27","current":-13.296895,"twenty":-33.299512,"median":-14.356338,"eighty":-13.867215,"marketCap":19891011},{"date":"2025-07-03","current":-13.774354,"twenty":-27.303638,"median":-14.27266,"eighty":-13.727614,"marketCap":20605249},{"date":"2025-07-11","current":-14.006506,"twenty":-17.177946,"median":-14.161274,"eighty":-13.727614,"marketCap":20952529},{"date":"2025-07-18","current":-13.851738,"twenty":-15.354982,"median":-14.154888,"eighty":-13.727614,"marketCap":20721009},{"date":"2025-07-25","current":-16.173259,"twenty":-16.219689,"median":-14.161274,"eighty":-13.727614,"marketCap":24193804},{"date":"2025-08-01","current":-13.464818,"twenty":-16.219689,"median":-14.199966,"eighty":-13.727614,"marketCap":20142210},{"date":"2025-08-08","current":-12.14929,"twenty":-16.049445,"median":-14.148502,"eighty":-13.573156,"marketCap":18174293},{"date":"2025-08-15","current":-12.265366,"twenty":-15.710284,"median":-14.056061,"eighty":-13.418388,"marketCap":18347933},{"date":"2025-08-22","current":-7.697345,"twenty":-15.447843,"median":-14.006506,"eighty":-13.015991,"marketCap":28547481},{"date":"2025-08-29","current":-6.307075,"twenty":-15.306558,"median":-13.929122,"eighty":-12.721932,"marketCap":23391328},{"date":"2025-09-05","current":-6.307075,"twenty":-15.146611,"median":-13.929122,"eighty":-12.474303,"marketCap":23391328},{"date":"2025-09-12","current":-6.578348,"twenty":-15.038217,"median":-13.851738,"eighty":-12.234412,"marketCap":24397407},{"date":"2025-09-19","current":-6.205348,"twenty":-14.9276,"median":-13.774354,"eighty":-7.507455,"marketCap":23014048},{"date":"2025-09-26","current":-6.049367,"twenty":-14.889578,"median":-13.773581,"eighty":-6.849619,"marketCap":22435553},{"date":"2025-10-03","current":-5.832349,"twenty":-14.826776,"median":-13.69697,"eighty":-6.578348,"marketCap":21630690},{"date":"2025-10-10","current":-6.307075,"twenty":-14.675296,"median":-13.542202,"eighty":-6.472551,"marketCap":23391328},{"date":"2025-10-17","current":-6.239257,"twenty":-14.561346,"median":-13.50351,"eighty":-6.415584,"marketCap":23139808},{"date":"2025-10-24","current":-5.879822,"twenty":-14.548195,"median":-13.387434,"eighty":-6.358617,"marketCap":21806754},{"date":"2025-10-31","current":-6.917438,"twenty":-14.538909,"median":-13.039206,"eighty":-6.374893,"marketCap":25655005},{"date":"2025-11-07","current":-8.524725,"twenty":-14.481047,"median":-12.845746,"eighty":-6.381675,"marketCap":31616021},{"date":"2025-11-14","current":-9.460613,"twenty":-14.381444,"median":-12.652286,"eighty":-6.415584,"marketCap":35086992},{"date":"2025-11-21","current":-5.852155,"twenty":-14.312928,"median":-12.458826,"eighty":-6.415584,"marketCap":30182359},{"date":"2025-11-28","current":-7.071353,"twenty":-14.306662,"median":-12.304058,"eighty":-6.374893,"marketCap":36470350},{"date":"2025-12-01","current":-7.071353,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"marketCap":36470350}],"updateTime":1789032748397},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APUS\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661226290","title":"Apimeds Pharmaceuticals US Enters Assignment and Transfer Agreement with Freet on August 19","url":"https://stock-news.laohu8.com/highlight/detail?id=2661226290","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661226290?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:31","pubTimestamp":1787347904,"startTime":"0","endTime":"0","summary":"BRIEF-Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On August 19Aug 21 -Apimeds Pharmaceuticals US IncAPUS.A:APIMEDS PHARMACEUTICALS US - ENTERS ASSIGNMENT AND TRANSFER AGREEMENT WITH FREET ON AUG 19, 2026 - SEC FILINGAPIMEDS PHARMACEUTICALS US - FREET ASSIGNS ALL APITOX-RELATED RIGHTS TO APIMEDS PHARMACEUTICALS - SEC FILINGAPIMEDS PHARMACEUTICALS US - RECEIVES 100% KOREAN CLINIC RIGHTS, 25% U.S. ROYALTY, 25% OVERSEAS REVENUE PARTICIPATION FOR APITOX - SEC FILINGAPIMEDS PHARMACEUTICALS US - ASSIGNED RIGHTS ARE FREE AND CLEAR OF PRIOR CLAIMS OR ENCUMBRANCES - SEC FILINGSource text: [ID:n0001213900-26-092680]Further company coverage:APUS.A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0JA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661907092","title":"Apimeds Secures Key Apitox Rights via FreeT Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2661907092","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661907092?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:27","pubTimestamp":1787347671,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Apimeds Pharmaceuticals US, Inc. ( ($APUS) ). On August 19, 2026, Apimeds Pharmaceuticals US, Inc. entered into...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apimeds-secures-key-apitox-rights-via-freet-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apimeds-secures-key-apitox-rights-via-freet-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661909292","title":"Apimeds Pharmaceuticals US - Freet Assigns All Apitox-Related Rights to Apimeds Pharmaceuticals - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2661909292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661909292?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:13","pubTimestamp":1787346814,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0JA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290926","title":"Apimeds Pharmaceuticals US - Receives 100% Korean Clinic Rights, 25% U.S. Royalty, 25% Overseas Revenue Participation for Apitox - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290926?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:13","pubTimestamp":1787346814,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0JA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":14,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/APUS\",params:#limit:6,delay:false,,,undefined,":[]}}